Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms 4Prostatic Neoplasms 3Lung Neoplasms 2Carcinoma, Renal Cell 2Weight Loss 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Sleep Apnea Syndromes 1Sezary Syndrome 1Sarcoma 1Recurrence 1Overweight 1Obesity, Morbid 1Obesity 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasm Metastasis 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Hypertension 1Hyperlipidemias 1Hemangioma 1Gastroesophageal Reflux 1Eczema 1Disease 1Digestive System Diseases 1Diabetes Mellitus, Type 2 1Diabetes Mellitus 1Dermatitis, Atopic 1Collagen Diseases 1

Interventions

Carboplatin 784Pemetrexed 607Cisplatin 545Paclitaxel 491pembrolizumab 464Docetaxel 440Gemcitabine 328Erlotinib Hydrochloride 307Radiotherapy 258Nivolumab 244Bevacizumab 233osimertinib 178Drug Therapy 164durvalumab 157atezolizumab 135Gefitinib 134Radiosurgery 133Vinorelbine 111Cetuximab 97130-nm albumin-bound paclitaxel 94Ipilimumab 86Magnetic Resonance Spectroscopy 84Taxes 79Surgical Procedures, Operative 74Afatinib 68Albumin-Bound Paclitaxel 66Specimen Handling 61Etoposide 61Cyclophosphamide 60tislelizumab 59

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Urine Specimen Collection × Clear all
NCT03998189 2021-11-05

Metabolic and Microbial Profiling of Lung Cancer

Wake Forest University Health Sciences

Phase NA Terminated
1 enrolled 4 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡